← Back to Clinical Trials
Recruiting NCT06926959

Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Tricuspid Regurgitation
Sponsor Sun Yat-sen University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 3,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2016-06-15
Completion 2030-06-15

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study is a multicenter cohort study including patients diagnosed with tricuspid regurgitation during hospitalization. The primary outcome of the study is all-cause death, and the secondary outcome is cardiovascular events. The prognostic risk factors of patients with tricuspid regurgitation are evaluated, and the prognostic models are constructed through the follow-up observation.

Eligibility Criteria

Inclusion Criteria: * Aged over 18 yrs. * Patients diagnosed with tricuspid regurgitation during hospitalization. Exclusion Criteria: * Patients unable to provide informed consent.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE TRICUSPID REGURGITATION TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}